254
Views
8
CrossRef citations to date
0
Altmetric
Pain

Sensory symptoms in low back pain—how do they matter?

, , , , , , , , & show all
Pages 657-667 | Received 18 May 2017, Accepted 25 Jul 2017, Published online: 24 Aug 2017

References

  • Schmidt CO, Raspe H, Pfingsten M, et al. Back pain in the German adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey. Spine (Phila Pa 1976) 2007;32:2005-11
  • Hardt J, Jacobsen C, Goldberg J, et al. Prevalence of chronic pain in a representative sample in the United States. Pain Med 2008;9:803-12
  • Hoy D, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum 2012;64:2028-37
  • Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363-70
  • Rapoport J, Jacobs P, Bell NR, et al. Refining the measurement of the economic burden of chronic diseases in Canada. Chronic Dis Canada 2004;25:13-21
  • Becker A, Held H, Redaelli M, et al. Low back pain in primary care: costs of care and prediction of future health care utilization. Spine (Phila Pa 1976) 2010;35:1714-20
  • Wenig CM, Schmidt CO, Kohlmann T, et al. Costs of back pain in Germany. Eur J Pain 2009;13:280-6
  • Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006;22:1911-20
  • Forster M, Mahn F, Gockel U, et al. Axial low back pain: one painful area—many perceptions and mechanisms. PLoS One 2013;8:e68273
  • http://www.iasp-pain.org/Taxonomy#Nociceptivepain
  • Baron R. Mechanisms of disease: neuropathic pain - a clinical perspective. Nature Clin Pract Neurol 2006;2:95-106
  • Oosterling A, Te Boveldt N, Verhagen C, et al. Neuropathic pain components in patients with cancer: prevalence, treatment, and interference with daily activities. Pain Pract 2015;16:413-21
  • Hiyama A, Watanabe M, Katoh H, et al. Evaluation of quality of life and neuropathic pain in patients with low back pain using the Japanese Orthopedic Association Back Pain Evaluation Questionnaire. Eur Spine 2015;24:503-12
  • Dworkin RH, Turk DC, Peirce-Sandner S, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010;149:177-93
  • Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-45
  • Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19
  • Turk DC, Dworkin RH, Revicki D, et al. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain 2008;137:276-85
  • Chiarotto A, Deyo RA, Terwee CB, et al. Core outcome domains for clinical trials in non-specific low back pain. Eur Spine J 2015;24:1127-42
  • Casarett D, Karlawish J, Sankar P, et al. Designing pain research from the patient’s perspective: what trial end points are important to patients with chronic pain? Pain Med 2001;2:309-16
  • Robinson ME, Brown JL, George SZ, et al. Multidimensional success criteria and expectations for treatment of chronic pain: the patient perspective. Pain Med 2005;6:336-45
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70
  • Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 2011;63(Suppl11):S454-S66
  • Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011;63(Suppl11):S467-S72
  • Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale manual. Windsor, Berkshire (UK): Nfer-Nelson; 1994
  • Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005;6:41-4
  • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001;33:337-43
  • Bullinger M. German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Social Sci Med 1995;41:1359-66
  • Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33
  • Magnussen L, Strand LI, Lygren H. Reliability and validity of the back performance scale: observing activity limitation in patients with back pain. Spine (Phila Pa 1976) 2004;29:903-7
  • Roese I, Kohlmann T, Raspe H. [Measuring functional capacity in backache patients in rehabilitation: a comparison of standardized questionnaires]. Die Rehab 1996;35:103-8
  • Freynhagen R, Baron R, Tolle T, et al. Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin 2006;22:529-37
  • Kern KU, Krings D, Waldmann-Rex S. [Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone]. MMW Fortschritte der Medizin 2014;156(Suppl2):54-63
  • Carley JA, Karp JF, Gentili A, et al. Deconstructing chronic low back pain in the older adult: step by step evidence and expert-based recommendations for evaluation and treatment: part IV: depression. Pain Med 2015;16:2098-108
  • Gossec L, Danre A, Combe B, et al. Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: an open-label assessment of 175 patients. Joint Bone Spine 2015;82:451-4
  • Maier C, Baron R, Tolle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010;150:439-50
  • Gierthmuhlen J, Binder A, Baron R. Mechanism-based treatment in complex regional pain syndromes. Nat Rev Neurol 2014;10:518-28
  • Reimer M, Helfert SM, Baron R. Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials. Curr Opin Support Palliat Care 2014;8:124-9
  • Sisignano M, Baron R, Scholich K, Geisslinger G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol 2014;10:694-707

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.